NO885820L - SYNERGISTIC COMBINATION OF DECARBOXYLASE INHIBITORS AND L-DOPA PELLET. - Google Patents

SYNERGISTIC COMBINATION OF DECARBOXYLASE INHIBITORS AND L-DOPA PELLET.

Info

Publication number
NO885820L
NO885820L NO88885820A NO885820A NO885820L NO 885820 L NO885820 L NO 885820L NO 88885820 A NO88885820 A NO 88885820A NO 885820 A NO885820 A NO 885820A NO 885820 L NO885820 L NO 885820L
Authority
NO
Norway
Prior art keywords
dopa
pellet
synergistic combination
decarboxylase inhibitors
decarboxylase
Prior art date
Application number
NO88885820A
Other languages
Norwegian (no)
Other versions
NO885820D0 (en
Inventor
Helmut Hettche
Manfred Albring
Original Assignee
Asta Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6343914&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO885820(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Asta Pharma Ag filed Critical Asta Pharma Ag
Publication of NO885820D0 publication Critical patent/NO885820D0/en
Publication of NO885820L publication Critical patent/NO885820L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Lock And Its Accessories (AREA)
  • Electrophonic Musical Instruments (AREA)

Abstract

A synergistic combination of L-dopa pellets and decarboxylase inhibitors as pharmaceuticals for Parkinson's disease.
NO88885820A 1987-12-31 1988-12-30 SYNERGISTIC COMBINATION OF DECARBOXYLASE INHIBITORS AND L-DOPA PELLET. NO885820L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3744646 1987-12-31

Publications (2)

Publication Number Publication Date
NO885820D0 NO885820D0 (en) 1988-12-30
NO885820L true NO885820L (en) 1989-07-03

Family

ID=6343914

Family Applications (1)

Application Number Title Priority Date Filing Date
NO88885820A NO885820L (en) 1987-12-31 1988-12-30 SYNERGISTIC COMBINATION OF DECARBOXYLASE INHIBITORS AND L-DOPA PELLET.

Country Status (13)

Country Link
EP (1) EP0324947B2 (en)
JP (1) JPH0296520A (en)
AT (1) ATE81971T1 (en)
AU (1) AU611512B2 (en)
CA (1) CA1315690C (en)
DE (1) DE3875716D1 (en)
DK (1) DK730488A (en)
ES (1) ES2052681T5 (en)
FI (1) FI886047A (en)
GR (2) GR3006182T3 (en)
IE (1) IE62643B1 (en)
NO (1) NO885820L (en)
PT (1) PT89350B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4983400A (en) * 1986-06-16 1991-01-08 Merck & Co., Inc. Controlled release combination of carbidopa/levodopa
DE4101873C2 (en) 1991-01-23 1993-12-09 Isis Pharma Gmbh Orally administrable drug form for the treatment of central dopamine deficiency states
US8815950B2 (en) 2003-08-29 2014-08-26 Janssen Biotech, Inc. Pharmaceutical compositions and method of using levodopa and carbidopa
EP2508174A1 (en) * 2011-04-06 2012-10-10 Ljiljana Sovic Brkicic Pharmaceutical composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3557292A (en) * 1968-08-16 1971-01-19 Hoffmann La Roche Compositions and methods for treating parkinson's disease with combinations of l-3,4-dihydroxyphenylalanine and a hydrazine
US3769424A (en) * 1970-10-01 1973-10-30 Merck & Co Inc Composition and method of treating dopamine deficiency in brain tissue
CH652025A5 (en) * 1981-09-14 1985-10-31 Hoffmann La Roche Pharmaceutical preparation.

Also Published As

Publication number Publication date
PT89350A (en) 1989-12-29
ES2052681T3 (en) 1994-07-16
NO885820D0 (en) 1988-12-30
DE3875716D1 (en) 1992-12-10
DK730488D0 (en) 1988-12-30
GR3006182T3 (en) 1993-06-21
ES2052681T5 (en) 1997-12-01
CA1315690C (en) 1993-04-06
ATE81971T1 (en) 1992-11-15
GR3024980T3 (en) 1998-01-30
JPH0296520A (en) 1990-04-09
PT89350B (en) 1993-09-30
IE62643B1 (en) 1995-02-22
DK730488A (en) 1989-07-01
EP0324947B1 (en) 1992-11-04
EP0324947A1 (en) 1989-07-26
EP0324947B2 (en) 1997-08-20
AU611512B2 (en) 1991-06-13
IE883894L (en) 1989-06-30
FI886047A (en) 1989-07-01
AU2758288A (en) 1989-07-06

Similar Documents

Publication Publication Date Title
BG47341A3 (en) Means for regulating plant growth
HUT43952A (en) Process for preparing pharmaceuticals comprising (-)-3-(3,4-dihydroxyphenyl)-l-alanine-methylester
HK74697A (en) Pharmaceutical therapeutic use of glutathione derivatives
IE821597L (en) Salts of n-subtituted-2-pyrrolidone-4-carboxylic acids as¹humectants
IL87566A0 (en) Medical composition for the treatment of diabetes comprising a benzamide derivative
NO885820D0 (en) SYNERGISTIC COMBINATION OF DECARBOXYLASE INHIBITORS AND L-DOPA PELLET.
AU3228489A (en) Treatment of equine livestock
GR3007995T3 (en)
NZ223293A (en) Beta-alkyl melatonins and pharmaceutical compositions
DE3877277D1 (en) INJECTION COMPOSITION CONTAINING MODIFIED TPA.
IT7850355A0 (en) COMPOSITION BASED ON DERIVATIVES OF ALPHA-HALOGENOMETHYLAMINOACIDS WITH AMINO ACID DECARBOXYLASE INHIBITING ACTIVITY AND PROCEDURE FOR ITS PRODUCTION
ES8203086A1 (en) 4-Methoxy-isophthalic Acid Picolylemide Monohydrate
NO920313D0 (en) PROCEDURE FOR THE PREPARATION OF RACEMIC AND OPTICAL ACTIVE 1,2,3,4-TETRAHYDROISOKINOLIN-3-CARBONIC ACID AND PRODUCTS THEREOF
EP0159602A3 (en) Compositions and methods for the therapeutic treatment of trace element deficiencies in ruminant animals
DE68905586D1 (en) BENZAMIDE DERIVATIVES AND THESE PLANT GROWTH REGULATORS.
IL84787A (en) Herbicidal composition containing n-(3-alkynyloxy-chloro-5-fluoro)tetrahydrophthalimide and a phenoxyalkanoic acid derivative
ATE46443T1 (en) MEDICATIONS FOR THE TREATMENT OF HERPES.
DE68906437D1 (en) L-PYROGLUTAMYL-L-CYSTEIN DIPEPTIDE WITH HIGH ANTI-CATARACTOGENIC EFFECT AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
EP0315182A3 (en) Medicament containing a polysaccharidic component from thuja plants as the active ingredient
NZ220242A (en) Regulating fertility in cattle by administering epostane
IT1216837B (en) SALTS OF N- (TRANS-P-IDROSSI-CICLOESIL) - (2 AMINO-3,5-DIBROMO) BENZYLAMINE EQUIPPED WITH MUCOLYTIC ACTIVITY.
ES8206538A1 (en) A pharmaceutical formulation of a vinca dimer.
IT7927414A0 (en) PATHOGENS, CONTAINING AS ACTIVE PHARMACEUTICAL COMPOSITION A MODIFIED STRAIN WITH INHIBITIVE ACTIVITY ON CORYNEBACTERIUM PARVUM NCTC 10390 FUNGENS.
IT8520066A0 (en) ANTI-STRESS COMPOSITIONS WITH BIOSTIMULANT ACTIVITY FOR PLANTS.
LV5396A3 (en) The device for long-lasting administration of a medicament relies on the rifle of the animal